Page Title

Tdap study enters phase III

Following the successful completion of phase II part of the Tdap study (tetanus, diphtheria and pertussis) Tadeus, phase III part will commence this week, which will include adults, adolescents and children to test the safety and immunogenicity of this vaccine. The Data Safety Monitoring Board had previously evaluated the phase II safety data as positive. Read more!